kr
71.30
Apr 26
Business Description
Aker BioMarine ASA
ISIN : NO0010886625
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.44 | |||||
Debt-to-Equity | 1.07 | |||||
Debt-to-EBITDA | 7.84 | |||||
Interest Coverage | 0.05 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.1 | |||||
Beneish M-Score | -2.54 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.8 | |||||
3-Year EBITDA Growth Rate | -7.5 | |||||
3-Year EPS without NRI Growth Rate | -27 | |||||
3-Year FCF Growth Rate | 69.8 | |||||
3-Year Book Growth Rate | 5.9 | |||||
Future 3-5Y Total Revenue Growth Rate | 14.37 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.8 | |||||
9-Day RSI | 61.23 | |||||
14-Day RSI | 63.29 | |||||
6-1 Month Momentum % | 68.63 | |||||
12-1 Month Momentum % | 61.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.57 | |||||
Quick Ratio | 0.94 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 302.58 | |||||
Days Sales Outstanding | 81.06 | |||||
Days Payable | 68.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -11.97 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 33.7 | |||||
Operating Margin % | 0.54 | |||||
Net Margin % | -2.66 | |||||
FCF Margin % | -0.68 | |||||
ROE % | -2.5 | |||||
ROA % | -1.1 | |||||
ROIC % | 0.06 | |||||
ROC (Joel Greenblatt) % | -0.01 | |||||
ROCE % | -0.01 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 18.73 | |||||
PS Ratio | 1.92 | |||||
PB Ratio | 1.62 | |||||
Price-to-Tangible-Book | 2.81 | |||||
Price-to-Operating-Cash-Flow | 19.28 | |||||
EV-to-EBIT | -14815.99 | |||||
EV-to-Forward-EBIT | 15.25 | |||||
EV-to-EBITDA | 19.44 | |||||
EV-to-Forward-EBITDA | 8.44 | |||||
EV-to-Revenue | 2.88 | |||||
EV-to-Forward-Revenue | 2.31 | |||||
EV-to-FCF | -422.27 | |||||
Earnings Yield (Greenblatt) % | -0.01 | |||||
FCF Yield % | -0.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aker BioMarine ASA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 3,573.445 | ||
EPS (TTM) (kr) | -0.846 | ||
Beta | -0.12 | ||
Volatility % | 43.74 | ||
14-Day RSI | 63.29 | ||
14-Day ATR (kr) | 3.159028 | ||
20-Day SMA (kr) | 67.67 | ||
12-1 Month Momentum % | 61.25 | ||
52-Week Range (kr) | 30.35 - 74.9 | ||
Shares Outstanding (Mil) | 87.67 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aker BioMarine ASA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aker BioMarine ASA Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Aker BioMarine ASA Frequently Asked Questions
What is Aker BioMarine ASA(OSL:AKBM)'s stock price today?
When is next earnings date of Aker BioMarine ASA(OSL:AKBM)?
Does Aker BioMarine ASA(OSL:AKBM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |